Stem cell advance brings bioengineered arteries closer to reality

July 10, 2017
Arterial endothelial cells derived from human pluripotent stem cells express activated NOTCH1 (in red, which is an arterial endothelial cell marker) and CD144 (in white, which is a pan endothelial cell marker). Credit: The Morgridge Institute for Research

Stem cell biologists have tried unsuccessfully for years to produce cells that will give rise to functional arteries and give physicians new options to combat cardiovascular disease, the world's leading cause of death.

But new techniques developed at the Morgridge Institute for Research and the University of Wisconsin-Madison have produced, for the first time, functional arterial cells at both the quality and scale to be relevant for disease modeling and clinical application.

Reporting in the July 10 issue of the journal Proceedings of the National Academy of Sciences (PNAS), scientists in the lab of stem cell pioneer James Thomson describe methods for generating and characterizing arterial endothelial cells—the cells that initiate artery development—that exhibit many of the specific functions required by the body.

Further, these cells contributed both to new artery formation and improved survival rate of mice used in a model for myocardial infarction. Mice treated with this cell line had an 83 percent survival rate, compared to 33 percent for controls.

"The cardiovascular diseases that kill people mostly affect the , and no one has been able to make those kinds of cells efficiently before," says Jue Zhang, a Morgridge assistant scientist and lead author. "The key finding here is a way to make arterial endothelial cells more functional and clinically useful."

Cardiovascular disease accounts for one in every three deaths each year in the United States, according to the American Heart Association, and claim more lives each year than all forms of cancer combined. The Thomson lab has made arterial engineering one of its top research priorities.

The challenge is that generic endothelial cells are relatively easy to create, but they lack true arterial properties and thus have little clinical value, Zhang says.

Morgridge Institute Regenerative biology researchers Jue Zhang and Matt Brown examine a part for a new bioreactor designed to help grow arterial tissue. Credit: The Morgridge Institute for Research

The research team applied two pioneering technologies to the project. First, they used single-cell RNA sequencing to identify the signaling pathways critical for arterial endothelial cell differentiation. They found about 40 genes of optimal relevance. Second, they used CRISPR-Cas9 gene editing technology that allowed them to create reporter cell lines to monitor arterial differentiation in real time.

"With this technology, you can test the function of these candidate genes and measure what percentage of cells are generating into our target arterial cells," says Zhang.

The research group developed a protocol around five key growth factors that make the strongest contributions to arterial cell development. They also identified some very common growth factors used in stem cell science, such as insulin, that surprisingly inhibit arterial endothelial cell differentiation.

"Our ultimate goal is to apply this improved cell derivation process to the formation of functional arteries that can be used in cardiovascular surgery," says Thomson, director of regenerative biology at Morgridge and UW-Madison professor of cell and regenerative biology. "This work provides valuable proof that we can eventually get a reliable source for functional arterial endothelial cells and make arteries that perform and behave like the real thing."

Thomson's team, along with many UW-Madison collaborators, is in the first year of a seven-year project supported by the National Institutes of Health (NIH) on the feasibility of developing artery banks suitable for use in human transplantation.

In many cases with vascular disease, patients lack suitable tissue from their own bodies for use in bypass surgeries. And growing arteries from an individual patient's would be cost prohibitive and take too long to be clinically useful.

The challenge will be not only to produce the arteries, but find ways to insure they are compatible and not rejected by patients.

"Now that we have a method to create these cells, we hope to continue the effort using a more universal donor cell line," says Zhang. The lab will focus on banked from a unique population of people who are genetically compatible donors for a majority of the population.

Explore further: Exposure to cardiovascular risk factors linked with arterial distensibility in adolescence

More information: Jue Zhang el al., "Functional characterization of human pluripotent stem cell-derived arterial endothelial cells," PNAS (2017). www.pnas.org/cgi/doi/10.1073/pnas.1702295114

Related Stories

Exposure to cardiovascular risk factors linked with arterial distensibility in adolescence

June 30, 2017
The longitudinal study on children and adolescents conducted by the Research Centre of Applied and Preventive Cardiovascular Medicine at the University of Turku, Finland, is unique worldwide. The study shows that cardiovascular ...

Stem cells yield nature's blueprint for body's vasculature

May 30, 2017
In the average adult human, there are an estimated 100,000 miles of capillaries, veins and arteries—the plumbing that carries life-sustaining blood to every part of the body, including vital organs such as the heart and ...

Epigenetic program leading to vessel differentiation

May 19, 2017
Clarification of how human blood vessels are constructed is desperately needed to advance regenerative medicine. A collaborative research group from Kumamoto University, Kyoto University, and the University of Tokyo in Japan ...

Recommended for you

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

Prototype ear plug sensor could improve monitoring of vital signs

November 16, 2017
Scientists have developed a sensor that fits in the ear, with the aim of monitoring the heart, brain and lungs functions for health and fitness.

Ancient enzyme could boost power of liquid biopsies to detect and profile cancers

November 16, 2017
Scientists are developing a set of medical tests called liquid biopsies that can rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample. Researchers at The University ...

FDA to crack down on risky stem cell offerings

November 16, 2017
U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received ...

Engineering the gut microbiome with 'good' bacteria may help treat Crohn's disease

November 15, 2017
Penn Medicine researchers have singled out a bacterial enzyme behind an imbalance in the gut microbiome linked to Crohn's disease. The new study, published online this week in Science Translational Medicine, suggests that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.